A previously healthy 22-year-old woman with a history with a healthy pregnancy presented 12 weeks after an uneventful delivery with progressive dyspnea and edema. Initial blood workup was relevant for an elevated B-type natriuretic peptide in 1641 pg/mL (reference: 0-100). Her electrocardiogram was unremarkable, and a chest X-ray revealed cardiomegaly with bilateral pleural effusion (Fig. 1A). A transthoracic echocardiogram (TTE) and a cardiac magnetic resonance imaging (MRI) showed generalized hypokinesia, a severely dilated left ventricle (LV) with reduced ejection fraction (rEF) of 28% and multiple mobile intracavitary thrombi (Fig. 1B and C), confirming a diagnosis of peripartum cardiomyopathy (PPCM). We started treatment with furosemide, dobutamine, and anticoagulation with nadroparin and warfarin. Three days after admission, we added treatment with metoprolol, spironolactone, sacubitril/valsartan, and gradually weaned dobutamine off.
On day 5 of in-hospital stay, she awoke with right-sided hemiparesis, and a brain MRI showed multiple supra and infratentorial ischemic lesions (Fig. 2), with no diffusion-weighted imaging/fluid-attenuated inversion recovery mismatch (DWI/FLAIR), consistent with acute cardioembolic strokes. We discharged her 12 days after admission on warfarin, spironolactone, furosemide, metoprolol, and sacubitril/valsartan. Six months after the event, she remained with right-sided hemiparesis, and a follow-up TTE showed resolution of the intracavitary thrombi without improvement of the LV dysfunction.
PPCM is characterized by LV dysfunction with rEF and symptoms of congestive heart failure during the end of pregnancy and early postpartum period, without an identifiable cause. It has a variable incidence between 1:100 and 1:20,000 deliveries worldwide1,2. PPCM is associated with a recovery rate of 50-80% to a normal LV systolic function (ejection fraction ≥ 50%), usually within the first 3-6 months, but 13% of women can develop persistent cardiomyopathy with rEF. Furthermore, up to 30% of patients may develop LV thrombi3. During the puerperium, selection of anticoagulation with either low-molecular-weight heparin or Vitamin K antagonists is recommended mainly on clinical experience gathered from other causes of heart failure2,3.
Worldwide, ischemic stroke during pregnancy and postpartum occurs in 12.2 per 100,000 pregnancies4, and in a Mexican series of 240 women, it occurred in 26.7% of patients5. The prevalence of PPCM-related stroke remains unknown4. PPCM complicated with intracavitary thrombi is an uncommon cause of stroke to acknowledge in a woman presenting with acute focal neurological signs during the last trimester of pregnancy or the early postpartum period.